@Article{info:doi/10.2196/jmir.6249,
author="Cheng, Hsin-Yi Kathy
and Chen, Li-Ying
and Cheng, Chih-Hsiu
and Ju, Yan-Ying
and Chen, Chia-Ling
and Tseng, Kevin C",
title="A Multimedia Child Developmental Screening Checklist: Design and Validation",
journal="J Med Internet Res",
year="2016",
month="Oct",
day="24",
volume="18",
number="10",
pages="e277",
keywords="child development; multimedia; screening; usability; Web-based; disability",
abstract="Background: Identifying disability early in life confers long-term benefits for children. The Taipei City Child Development Screening tool, second version (Taipei II) provides checklists for 13 child age groups from 4 months to 6 years. However, the usability of a text-based screening tool largely depends on the literacy level and logical reasoning ability of the caregivers, as well as language barriers caused by increasing numbers of immigrants. Objective: The objectives of this study were to (1) design and develop a Web-based multimedia version of the current Taipei II developmental screening tool, and (2) investigate the measurement equivalence of this multimedia version to the original paper-based version. Methods: To develop the multimedia version of Taipei II, a team of experts created illustrations, translations, and dubbing of the original checklists. The developmental screening test was administered to a total of 390 primary caregivers of children aged between 4 months and 6 years. Results: Psychometric testing revealed excellent agreement between the paper and multimedia versions of Taipei II. Good to excellent reliabilities were demonstrated for all age groups for both the cross-mode similarity (mode intraclass correlation range 0.85-0.96) and the test-retest reliability (r=.93). Regarding the usability, the mean score was 4.80 (SD 0.03), indicating that users were satisfied with their multimedia website experience. Conclusions: The multimedia tool produced essentially equivalent results to the paper-based tool. In addition, it had numerous advantages, such as it can facilitate active participation and promote early screening of target populations. ClinicalTrial: Clinicaltrials.gov NCT02359591; https://clinicaltrials.gov/ct2/show/NCT02359591 (Archived by WebCite at http://www.webcitation.org/6l21mmdNn) ",
issn="1438-8871",
doi="10.2196/jmir.6249",
url="http://www.jmir.org/2016/10/e277/",
url="https://doi.org/10.2196/jmir.6249",
url="http://www.ncbi.nlm.nih.gov/pubmed/27777218"
}